Category: Health

  • This fusion company wants to use its tech to fight cancer | Miles O'Brien Productions

    This fusion company wants to use its tech to fight cancer

    A private venture pursuing fusion power technology has stumbled on a potent way to kill cancer cells while methodically marching toward the Holy Grail of energy production. TAE, formerly Tri Alpha Energy has notched several key milestones on the road toward making fusion practical–thanks to some deep-pocket funding from the likes of Paul Allen. Fusion…

    Read More

  • Potential Zika vaccine fast-tracked by FDA | Miles O'Brien Productions

    Potential Zika vaccine fast-tracked by FDA

    A Zika vaccine candidate developed by Japanese pharmaceutical giant Takeda has entered an accelerated FDA review process. Zika, a mostly mosquito-spread infection that can cause serious birth defects, is still an issue. Although it made waves mostly during its 2016 outbreak, concerns remain about a resurgence of Zika and the CDC still lists vast swatches…

    Read More

  • For this doctor, a son’s death by overdose inspires his mission to rescue others

    For more, go to:

    Read More

  • Synthetic opioids on the rise in America | Miles O'Brien Productions

    New statistics show synthetic opioids are driving overdose crisis in America

    The Centers for Disease Control and Prevention (CDC) have released their final tally of fatal drug overdoses for 2016. All drug overdoses rose 21%, from 52,404 in 2015 to 63,632 in 2016. The vast majority of these were opioid overdoses, which rose 27% to 42,249 from the previous year. At this point, the opioid epidemic…

    Read More

  • Understanding the science of pain, with the help of virtual reality

    PBS NewsHour segment, aired 10/4/17.

    Read More

  • Prescription opioid overdoses down, but opioid substitute overdoses way up

    A new Stanford study shows that initiatives aimed to curb opioid abuse have been a double-edged sword.

    Read More

Get our latest stories delivered to your inbox.